Eslicarbazepine

Eslicarbazepine is an oral anticonvulsant indicated for the adjunctive treatment of partial seizures.

Product Specifications

CAS Number

[104746-04-5]

Product Name Alternative

BIA 2-194

UNSPSC

12352005

Hazard Statement

H315, H319, H320

Target

Beta-secretase; Sodium Channel

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/Eslicarbazepine.html

Purity

99.94

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

O=C(N)N1C2=CC=CC=C2C[C@@H](C3=CC=CC=C31)O

Molecular Formula

C15H14N2O2

Molecular Weight

254.29

Precautions

H315, H319, H320

References & Citations

[1]Finelli E, et al. Patch testing in a case of eslicarbazepine and carbamazepine induced cutaneous reaction. Eur Ann Allergy Clin Immunol. 2018 Sep;50 (5) :229-231.|[2]Sibhghatulla Shaikh, et al. Aptiom (Eslicarbazepine Acetate) as a Dual Inhibitor of β-Secretase and Voltage-Gated Sodium Channel: Advancement in Alzheimer's Disease-Epilepsy Linkage via an Enzoinformatics Study. CNS & Neurological Disorders Drug Targets Volume 13 , Issue 7 , 2014.